Stablepoint Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.8M Buy
74,189
+1,052
+1% +$84.9K 0.8% 43
2026
Q1
$6.34M Buy
73,137
+2,302
+3% +$221K 0.94% 34
2025
Q4
$6.8M Sell
70,835
-57
-0.1% -$5.54K 1.06% 23
2025
Q3
$6.75M Buy
70,892
+1,620
+2% +$149K 1.07% 24
2025
Q2
$6.04M Buy
69,272
+1,606
+2% +$136K 1.03% 27
2025
Q1
$6.08M Buy
67,666
+1,977
+3% +$177K 1.1% 23
2024
Q4
$5.25M Buy
65,689
+898
+1% +$77.7K 0.96% 29
2024
Q3
$5.83M Buy
64,791
+133
+0.2% +$11.2K 1.06% 23
2024
Q2
$5.17M Buy
64,658
+7,506
+13% +$615K 1% 31
2024
Q1
$4.98M Buy
57,152
+5,765
+11% +$492K 1.01% 32
2023
Q4
$4.23M Buy
+51,387
New +$3.92M 1.09% 32

Other funds holding MDT

Stablepoint Partners's MDT Position: Q2 2026 in Review

Stablepoint Partners increased its Medtronic (MDT) stake by 1.4% in Q2 2026, buying an estimated $84.9K and bringing the position to 74,189 shares worth $5.8M. The position accounts for 0.8% of the portfolio, ranked #43.

Stablepoint Partners first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.8M in Q4 2025. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stablepoint Partners held 74,189 shares of Medtronic worth $5.8M as of Q2 2026.
  • Stablepoint Partners bought 1,052 Medtronic shares in Q2 2026, an estimated $84.9K.
  • Medtronic made up 0.8% of Stablepoint Partners's portfolio in Q2 2026, its #43 holding.
  • Stablepoint Partners first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Stablepoint Partners's Medtronic position peaked at $6.8M in Q4 2025.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.